
### [NCIT:C6450](http://purl.obolibrary.org/obo/NCIT_C6450)
**Label:** Thymus Epithelial Neoplasm

**Subclasses:** [NCIT:C35718](http://purl.obolibrary.org/obo/NCIT_C35718) (Thymic Undifferentiated Carcinoma), [NCIT:C7904](http://purl.obolibrary.org/obo/NCIT_C7904) (Invasive Malignant Thymoma), [NCIT:C6457](http://purl.obolibrary.org/obo/NCIT_C6457) (Thymic Mucoepidermoid Carcinoma), [NCIT:C6459](http://purl.obolibrary.org/obo/NCIT_C6459) (Thymic Adenocarcinoma), [NCIT:C6458](http://purl.obolibrary.org/obo/NCIT_C6458) (Thymic Adenosquamous Carcinoma), [NCIT:C7569](http://purl.obolibrary.org/obo/NCIT_C7569) (Thymic Carcinoma), [NCIT:C95048](http://purl.obolibrary.org/obo/NCIT_C95048) (Ectopic Cervical Thymoma), [NCIT:C6453](http://purl.obolibrary.org/obo/NCIT_C6453) (Invasive Thymoma), [NCIT:C136350](http://purl.obolibrary.org/obo/NCIT_C136350) (Stage III Thymoma AJCC v8), [NCIT:C6430](http://purl.obolibrary.org/obo/NCIT_C6430) (Thymic Carcinoid Tumor), [NCIT:C27937](http://purl.obolibrary.org/obo/NCIT_C27937) (Thymic Papillary Adenocarcinoma), [NCIT:C6455](http://purl.obolibrary.org/obo/NCIT_C6455) (Thymic Squamous Cell Carcinoma), [NCIT:C6454](http://purl.obolibrary.org/obo/NCIT_C6454) (Thymoma Type A), [NCIT:C45722](http://purl.obolibrary.org/obo/NCIT_C45722) (Combined Thymic Epithelial Neoplasm), [NCIT:C136353](http://purl.obolibrary.org/obo/NCIT_C136353) (Stage IV Thymoma AJCC v8), [NCIT:C7386](http://purl.obolibrary.org/obo/NCIT_C7386) (Encapsulated Thymoma), [NCIT:C45707](http://purl.obolibrary.org/obo/NCIT_C45707) (Metaplastic Thymoma), [NCIT:C45709](http://purl.obolibrary.org/obo/NCIT_C45709) (Sclerosing Thymoma), [NCIT:C7905](http://purl.obolibrary.org/obo/NCIT_C7905) (Recurrent Malignant Thymoma), [NCIT:C136325](http://purl.obolibrary.org/obo/NCIT_C136325) (Stage III Thymus Epithelial Neoplasm AJCC v8), [NCIT:C6889](http://purl.obolibrary.org/obo/NCIT_C6889) (Malignant Type B2 Thymoma), [NCIT:C3411](http://purl.obolibrary.org/obo/NCIT_C3411) (Thymoma), [NCIT:C136323](http://purl.obolibrary.org/obo/NCIT_C136323) (Stage II Thymus Epithelial Neoplasm AJCC v8), [NCIT:C136345](http://purl.obolibrary.org/obo/NCIT_C136345) (Thymoma by AJCC v8 Stage), [NCIT:C136322](http://purl.obolibrary.org/obo/NCIT_C136322) (Stage I Thymus Epithelial Neoplasm AJCC v8), [NCIT:C6886](http://purl.obolibrary.org/obo/NCIT_C6886) (Malignant Type AB Thymoma), [NCIT:C7612](http://purl.obolibrary.org/obo/NCIT_C7612) (Malignant Thymoma), [NCIT:C136329](http://purl.obolibrary.org/obo/NCIT_C136329) (Stage IV Thymus Epithelial Neoplasm AJCC v8), [NCIT:C7997](http://purl.obolibrary.org/obo/NCIT_C7997) (Thymoma Type B3), [NCIT:C6885](http://purl.obolibrary.org/obo/NCIT_C6885) (Thymoma Type AB), [NCIT:C7996](http://purl.obolibrary.org/obo/NCIT_C7996) (Malignant Type B1 Thymoma), [NCIT:C7999](http://purl.obolibrary.org/obo/NCIT_C7999) (Malignant Type A Thymoma), [NCIT:C136349](http://purl.obolibrary.org/obo/NCIT_C136349) (Stage II Thymoma AJCC v8), [NCIT:C6888](http://purl.obolibrary.org/obo/NCIT_C6888) (Thymoma Type B2), [NCIT:C7998](http://purl.obolibrary.org/obo/NCIT_C7998) (Thymic Lymphoepithelioma-Like Carcinoma), [NCIT:C136348](http://purl.obolibrary.org/obo/NCIT_C136348) (Stage I Thymoma AJCC v8), [NCIT:C6887](http://purl.obolibrary.org/obo/NCIT_C6887) (Thymoma Type B1), [NCIT:C115444](http://purl.obolibrary.org/obo/NCIT_C115444) (Recurrent Combined Thymic Epithelial Neoplasm), [NCIT:C6463](http://purl.obolibrary.org/obo/NCIT_C6463) (Thymic Sarcomatoid Carcinoma), [NCIT:C7114](http://purl.obolibrary.org/obo/NCIT_C7114) (Thymoma Type B), [NCIT:C6460](http://purl.obolibrary.org/obo/NCIT_C6460) (Thymic Small Cell Carcinoma), [NCIT:C136320](http://purl.obolibrary.org/obo/NCIT_C136320) (Thymus Epithelial Neoplasm by AJCC v8 Stage), [NCIT:C6462](http://purl.obolibrary.org/obo/NCIT_C6462) (Thymic Clear Cell Carcinoma), [NCIT:C6461](http://purl.obolibrary.org/obo/NCIT_C6461) (Thymic Large Cell Neuroendocrine Carcinoma), [NCIT:C45638](http://purl.obolibrary.org/obo/NCIT_C45638) (Intrapulmonary Thymoma), [NCIT:C45639](http://purl.obolibrary.org/obo/NCIT_C45639) (Mediastinal Thymoma), [NCIT:C45719](http://purl.obolibrary.org/obo/NCIT_C45719) (Thymic Atypical Carcinoid Tumor), [NCIT:C9080](http://purl.obolibrary.org/obo/NCIT_C9080) (Noninvasive Malignant Thymoma), 

**Class expressions from DL-Learner:**

- Thing 51.96%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) 43.69%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39072](http://purl.obolibrary.org/obo/NCIT_C39072) (Erk1/Erk2 MAPK Signaling Pathway))) 43.69%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39071](http://purl.obolibrary.org/obo/NCIT_C39071) (Neuronal Survival Pathway))) 43.69%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39069](http://purl.obolibrary.org/obo/NCIT_C39069) (ErbB3 Receptor Recycling Pathway))) 43.69%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39067](http://purl.obolibrary.org/obo/NCIT_C39067) (EPO Signaling Pathway))) 43.69%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39066](http://purl.obolibrary.org/obo/NCIT_C39066) (Erythropoietin Neuroprotection Pathway))) 43.69%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39059](http://purl.obolibrary.org/obo/NCIT_C39059) (Map Kinase Inactivation of SMRT Corepressor Pathway))) 43.69%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39058](http://purl.obolibrary.org/obo/NCIT_C39058) (EGF Signaling Pathway))) 43.69%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39056](http://purl.obolibrary.org/obo/NCIT_C39056) (Vesicle Transport Pathway))) 43.69%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39055](http://purl.obolibrary.org/obo/NCIT_C39055) (Phospholipid Signaling Pathway))) 43.69%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39054](http://purl.obolibrary.org/obo/NCIT_C39054) (Extracellular Matrix Binding Pathway))) 43.69%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39040](http://purl.obolibrary.org/obo/NCIT_C39040) (CTCF Pathway))) 43.69%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39021](http://purl.obolibrary.org/obo/NCIT_C39021) (Cell Migration Pathway))) 43.69%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39016](http://purl.obolibrary.org/obo/NCIT_C39016) (EGF Receptor Downregulation by CBL Pathway))) 43.69%


